Tech • AI • Robotics
50 articles analyzed by AI / 128 total
A 2026 report by 36Kr details the rapid expansion of the AI healthcare market in China, surpassing a trillion yuan in market size. It highlights key industry leaders and emerging growth trends shaping this competitive sector.
Brightn launched in August 2026 a comprehensive mental health benefit for employers in the U.S. that combines AI-powered daily support with licensed therapy through OpenLoop Health, aiming to increase access and improve workforce mental wellness.
Fairview Health Services is deploying AI technology to enhance the human-centered aspect of healthcare, improving patient empathy, personalization, and overall care outcomes, marking a significant innovation in health service delivery as of 2026.
Harrogate adopted AI technology in 2026 to accelerate breast cancer testing, enhancing diagnostic speed and accuracy, which is expected to improve early detection and healthcare efficiency in oncology.
FDB announced the first commercial deployment of its Ambient AI Script Agent™ with Tebra in 2026, extending AI usage from clinical documentation to prescription management, signaling a milestone in practical AI integration in healthcare workflows.
Tempus received FDA clearance in 2026 for an AI tool that detects pulmonary hypertension indicators from standard ECGs, achieving a key regulatory milestone for AI in cardiovascular diagnostics.
Federated learning is being applied in India’s healthcare sector in 2026 to enable AI development without moving patient data, enhancing privacy and compliance while improving diagnostics and treatments through localized AI training.
The World Health Organization in 2026 recognized Clalit’s AI safety model as a global benchmark for healthcare AI safety and ethics, setting important standards for AI implementation in medical practice.
The U.S. FDA is preparing regulatory guidance on medical devices that use generative AI in 2026, reflecting the increasing adoption of advanced AI technologies in healthcare devices and the need for safety standards.
Alibaba’s AI model improved liver cancer diagnosis efficiency by 20% in clinical trials conducted in 2023, demonstrating significant gains in accuracy and speed of detection through AI innovation.